Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (43)

2023

  1. Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant

    Expert Review of Neurotherapeutics, Vol. 23, Núm. 2, pp. 179-186

  2. Study about the Manchester Triage System subtriage in patients that visited the Emergency Department due to headache

    Neurologia, Vol. 38, Núm. 4, pp. 270-277

2022

  1. Headache education and management in Cameroon: a healthcare provider study

    Acta Neurologica Belgica, Vol. 122, Núm. 1, pp. 75-81

  2. Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection

    Cephalalgia, Vol. 42, Núm. 14, pp. 1521-1531

2021

  1. Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients

    Expert Review of Neurotherapeutics, Vol. 21, Núm. 1, pp. 123-130

  2. Clinical Characteristics and Therapeutic Results in a Series of 68 Patients with Occipital Neuralgia

    Pain medicine (Malden, Mass.), Vol. 22, Núm. 2, pp. 396-401

  3. Daily headache in chronic migraine is a predictive factor of response in patients who had completed three sessions of OnabotulinumtoxinA

    Toxins, Vol. 13, Núm. 6

  4. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown

    Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092

  5. Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine

    Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091

  6. Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class

    Neurologia

  7. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature

    European Journal of Neurology, Vol. 28, Núm. 11, pp. 3820-3825

  8. Linear Headache: A Novel Entity or a Variant of Nummular Headache? Clinical Characteristics and Treatment Response in a Series of 16 Patients

    Pain medicine (Malden, Mass.), Vol. 22, Núm. 5, pp. 1158-1166

  9. Management of thunderclap headache in the emergency room: A retrospective cohort study

    Cephalalgia, Vol. 41, Núm. 6, pp. 711-720

  10. Multimodal fusion analysis of structural connectivity and gray matter morphology in migraine

    Human Brain Mapping, Vol. 42, Núm. 4, pp. 908-921

  11. Pain catastrophising in a population of patients with migraine

    Neurologia, Vol. 36, Núm. 1, pp. 24-28

  12. Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study

    BMC Neurology, Vol. 21, Núm. 1

  13. Previous History of Migraine Is Associated With Fatigue, but Not Headache, as Long-Term Post-COVID Symptom After Severe Acute Respiratory SARS-CoV-2 Infection: A Case-Control Study

    Frontiers in Human Neuroscience, Vol. 15

  14. Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study

    Scientific Reports, Vol. 11, Núm. 1

  15. Secondary Nummular Headache: A New Case Series and Review of the Literature

    Pain medicine (Malden, Mass.), Vol. 22, Núm. 11, pp. 2718-2727

  16. Supratrochlear neuralgia: First case of terminal branch neuralgia as the presenting symptom of vasculitis

    Neurologia